Supervised Computerized Active Program for People With Post-COVID Syndrome (SuperCAP Study)
NCT ID: NCT06315894
Last Updated: 2025-12-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2023-10-03
2024-09-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Stage 1 will involve the composition of a focus group previous to the effectiveness study development.
The work with this focus group will have several aims, among them, mainly, to participate in the design of the intervention program, and to provide feedback on the study follow-up.
Stage 2 will include the effectiveness study. This stage will comprise the initiation of the intervention program, study follow-up, and dissemination of the results in the end of the project.
Two study groups will participate: the Intervention Group and the Control Group.
The Intervention Group will be comprised by people with post-COVID condition who will follow the intervention program proposed.
The Control Group will be comprised by people with post-COVID condition who will not follow the program.
Both groups will fulfill the same study participation criteria.
The intervention will consist of the follow-up of a distance program via mobile/tablet. This program will integrate different games and exercises always with the objective of stimulating the cognitive functioning and the emotional status.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experimental
People with post-COVID syndrome following the intervention
SuperCAP Program
Distance program including tasks and exercises to improve cognitive, emotional, and functional status.
The intervention will be applied via cell phone and will have a duration of 3 months (12 weeks).
Tasks and exercises will be performed 5 days per week. Contents of the program will include daily exercises, daily games, daily videos, and weekly videos.
They will address cognitive functions, daily habits, and lifestyle factors in general.
Compliance will be monitored to control the adherence to the intervention. The program has been designed specifically for people with post-COVID syndrome.
Control
People with post-COVID syndrome not following the intervention
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
SuperCAP Program
Distance program including tasks and exercises to improve cognitive, emotional, and functional status.
The intervention will be applied via cell phone and will have a duration of 3 months (12 weeks).
Tasks and exercises will be performed 5 days per week. Contents of the program will include daily exercises, daily games, daily videos, and weekly videos.
They will address cognitive functions, daily habits, and lifestyle factors in general.
Compliance will be monitored to control the adherence to the intervention. The program has been designed specifically for people with post-COVID syndrome.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age of 18-65 years old.
* Presence of self-reported cognitive complaints associated with post-COVID infection.
* Positive and favorable attitude on the use of electronic devices.
* Will to participate in a stimulation program for improvement of cognitive symptoms.
* Availability of cell phone and computer or tablet with the minimum technical features considered.
Exclusion Criteria
* Current participation in a trial or program for improvement of post-COVID symptoms.
* Any condition that in the opinion of the investigator would make study participation unsafe, complicate interpretation of study outcome data, interfere with achieving the study objectives, or otherwise could impair the subject's ability to complete the study.
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Institut de Recerca de la SIDA IrsiCaixa
UNKNOWN
Germans Trias i Pujol Hospital
OTHER
Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Germans Trias I Pujol Hospital
Badalona, Barcelona, Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PI-22-191
Identifier Type: -
Identifier Source: org_study_id